This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

Treatment After Irinotecan-based Frontline Therapy: Maintenance With Erbitux (in Patients wtRAS mCRC) (TIME)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02404935
Recruitment Status : Completed
First Posted : April 1, 2015
Last Update Posted : March 24, 2022
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 1, 2020
Actual Study Completion Date : October 25, 2021